Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
20%
Ph phase_3
1
20%
Ph phase_1
1
20%
Ph phase_4
2
40%

Phase Distribution

1

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
2(40.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(3)

Detailed Status

Completed3
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (20.0%)
Phase 31 (20.0%)
Phase 42 (40.0%)
N/A1 (20.0%)

Trials by Status

not_yet_recruiting240%
completed360%

Recent Activity

0 active trials
Showing 5 of 5
not_yet_recruitingnot_applicable

Tafenoquine Combinations for Improved Radical Cure Efficacy of Plasmodium Vivax

NCT07533136
not_yet_recruitingphase_4

Investigating the Pharmacology of Tafenoquine in Papua New Guinean Children With Uncomplicated Malaria

NCT07403643
completedphase_3

Improving Maternal heAlth by Reducing Malaria in African HIV Women

NCT03671109
completedphase_4

Malaria Therapeutic Efficacy Study, Rwanda

NCT04767217
completedphase_1

Efficacy, Safety, and Tolerability of Dihydroartemisinin-piperaquine + Mefloquine Compared to Dihydroartemisinin-piperaquine or Artesunate-mefloquine in Patients With Uncomplicated Falciparum Malaria in Cambodia

NCT02612545

Clinical Trials (5)

Showing 5 of 5 trials
NCT07533136Not Applicable

Tafenoquine Combinations for Improved Radical Cure Efficacy of Plasmodium Vivax

Not Yet Recruiting
NCT07403643Phase 4

Investigating the Pharmacology of Tafenoquine in Papua New Guinean Children With Uncomplicated Malaria

Not Yet Recruiting
NCT03671109Phase 3

Improving Maternal heAlth by Reducing Malaria in African HIV Women

Completed
NCT04767217Phase 4

Malaria Therapeutic Efficacy Study, Rwanda

Completed
NCT02612545Phase 1

Efficacy, Safety, and Tolerability of Dihydroartemisinin-piperaquine + Mefloquine Compared to Dihydroartemisinin-piperaquine or Artesunate-mefloquine in Patients With Uncomplicated Falciparum Malaria in Cambodia

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5